Northside Hospital, Inc.
Clinical trials sponsored by Northside Hospital, Inc., explained in plain language.
-
New hope for Hard-to-Treat leukemia? early trial combines three drugs
Disease control Not yet recruitingThis early-phase trial is testing a new drug called axatilimab added to two standard chemotherapy drugs (decitabine and venetoclax) for people with acute myeloid leukemia (AML) that has a TP53 mutation or deletion. The study aims to find the safest dose of axatilimab and see how …
Phase: PHASE1 • Sponsor: Northside Hospital, Inc. • Aim: Disease control
Last updated Jun 22, 2026 11:58 UTC
-
An open-label, phase i trial, with an expansion cohort: macrophage conditioning to synergize with CAR-T in high-risk lymphoma (MAC-SHIFT)
Not yet recruitingAxatilimab + CAR-T in High-Risk Lymphoma
Phase: PHASE1 • Sponsor: Northside Hospital, Inc.
Last updated Jun 18, 2026 11:48 UTC